Stay updated on KRAS G12C Inhibitor Clinical Trial

Sign up to get notified when there's something new on the KRAS G12C Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KRAS G12C Inhibitor Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T12:08:22.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-24T11:45:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:02:58.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T12:25:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Two new history entries (versions 54 and 55) were added, introducing updates to the Study Status and Contacts/Locations sections; an older entry from 2026-08-27 was removed.
    Difference
    0.4%
    Check dated 2026-09-26T16:21:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history and an older revision v3.6.6 was removed, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-09-19T18:36:47.000Z thumbnail image

Stay in the know with updates to KRAS G12C Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KRAS G12C Inhibitor Clinical Trial page.